John Pisano
biochemist
John Pisano is a biochemist who conducted pioneering research in the 1980s on the therapeutic potential of animal venoms, including the Gila monster's saliva, which led to the discovery of Exendin-4, a key component in diabetes treatments.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
8,014
Power
648$
Sentiment
6.00
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 6.00 | 0.09% | +0% | 8,654,622 | 8,014 | $700,000 | 648$ |
| Totals | 1 | 8,654,622 | 8,014 | $700,000 | 648$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
John Pisano researched various animal venoms at the National Institutes of Health in the 1980s.
6
Emily Elconin
Fabian Schmidt
Jean Pierre Raufman
John Eng
Rocio Salas Whalen
Baptist Gallwitz
Dale Denardo
Neue Zürcher Zeitung: Gila-Monster und Exendin-4: Der Naturstoff hinter Ozempic